MarketCap
Facebook
X
TelegramAnnual report 2022
added 03-30-2023
Apollo Endosurgery Operating Income 2011-2025 | APEN
Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.
FormulaOperating profit = Revenue – Operating expensesFeatures of the metric
- Evaluates business efficiency
Shows how well the company controls its production and administrative costs. - Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies. - Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.
If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.
Annual Operating Income Apollo Endosurgery
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -31.4 M | -19.2 M | -15.8 M | -23.5 M | -40.1 M | -22.4 M | -20.8 M | -16.7 M | -17.8 M | -7.59 M | -5.56 M | -3.71 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -3.71 M | -40.1 M | -18.7 M |
Quarterly Operating Income Apollo Endosurgery
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | -6.29 M | - | -7.25 M | - | -4.5 M | -5.24 M | -3.75 M | - | -1.57 M | -4.3 M | -6.68 M | - | -6.86 M | -7.2 M | -2.54 M | - | -8.1 M | -7.51 M | -7.63 M | - | -4.28 M | -5.47 M | -6.81 M | - | -3.72 M | -6.26 M | -3.02 M | - | -2.23 M | -3.27 M | -3.02 M | - | -3.57 M | -4.33 M | -3.1 M | - | -1.78 M | -1.93 M | -1.48 M | - | -1.35 M | -1.08 M | -1.23 M | - | -701 K | -632 K | 96 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 96 K | -8.1 M | -3.96 M |
Operating Income of other stocks in the Medical devices industry
| Issuer | Operating Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Abiomed
ABMD
|
230 M | - | - | $ 17.2 B |  USA |
 |
Acutus Medical
AFIB
|
-11.7 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
-1.27 M | - | 3.58 % | $ 2.21 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
-5.13 M | $ 9.33 | 0.21 % | $ 670 M |  Israel |
 |
Apyx Medical Corporation
APYX
|
-17.3 M | $ 3.42 | -0.58 % | $ 118 M | USA |
 |
Boston Scientific Corporation
BSX
|
2.6 B | $ 96.41 | 0.41 % | $ 142 B | USA |
 |
Bio-Rad Laboratories
BIO
|
269 M | $ 303.88 | - | $ 8.57 B | USA |
 |
Conformis
CFMS
|
-46.3 M | - | - | $ 16.4 M | USA |
 |
Cardiovascular Systems
CSII
|
-35.8 M | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
-156 M | - | -10.19 % | $ 1.99 M | USA |
 |
BioSig Technologies
BSGM
|
-12.9 M | - | 37.08 % | $ 85.7 M | USA |
 |
Electromed
ELMD
|
9.66 M | $ 28.51 | 0.04 % | $ 241 M | USA |
 |
Bruker Corporation
BRKR
|
253 M | $ 48.4 | 0.8 % | $ 7.21 K | USA |
 |
Abbott Laboratories
ABT
|
6.82 B | $ 124.81 | -0.02 % | $ 217 B | USA |
 |
Eargo
EAR
|
-112 M | - | - | $ 10.2 M | USA |
 |
EDAP TMS S.A.
EDAP
|
-20.5 M | $ 3.3 | -2.94 % | $ 123 M |  France |
 |
Neovasc
NVCN
|
-31.1 M | - | - | $ 111 M |  Canada |
 |
InMode Ltd.
INMD
|
113 M | $ 14.73 | 0.72 % | $ 1.17 B | Israel |
 |
Dynatronics Corporation
DYNT
|
-2.45 M | - | 14.99 % | $ 929 K | USA |
 |
IRIDEX Corporation
IRIX
|
-10 M | $ 1.23 | -0.07 % | $ 19.8 M | USA |
 |
IRadimed Corporation
IRMD
|
22 M | $ 98.0 | 0.56 % | $ 1.24 B | USA |
 |
Second Sight Medical Products
EYES
|
-24.7 M | - | -0.97 % | $ 54.4 M | USA |
 |
LivaNova PLC
LIVN
|
129 M | $ 63.0 | 0.21 % | $ 3.42 B |  Britain |
|
LENSAR
LNSR
|
-10.7 M | $ 11.95 | - | $ 138 M | USA |
 |
Align Technology
ALGN
|
608 M | $ 158.18 | -0.12 % | $ 11.8 B | USA |
 |
NanoVibronix
NAOV
|
-3.58 M | - | - | $ 1.08 M | USA |
 |
Accuray Incorporated
ARAY
|
7.84 M | $ 0.82 | -0.25 % | $ 84.3 M | USA |
 |
Avinger
AVGR
|
-16.6 M | - | -20.74 % | $ 369 K | USA |
 |
ClearPoint Neuro
CLPT
|
-19.7 M | $ 14.08 | 0.43 % | $ 381 M | USA |
 |
FONAR Corporation
FONR
|
5.31 M | $ 14.4 | -0.35 % | $ 94.4 M | USA |
 |
AxoGen
AXGN
|
-3.29 M | $ 32.75 | -0.15 % | $ 1.45 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
-64.9 M | - | - | $ 3.31 B | USA |
 |
GBS
GBS
|
-10.6 M | - | -0.57 % | $ 7.12 M | USA |
 |
CONMED Corporation
CNMD
|
200 M | $ 40.81 | 0.1 % | $ 1.26 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-35 M | $ 17.67 | 1.9 % | $ 408 M | USA |
 |
Globus Medical
GMED
|
166 M | $ 88.58 | 0.19 % | $ 12 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
28.4 M | $ 12.79 | 1.35 % | $ 985 M | USA |
 |
Aziyo Biologics
AZYO
|
-30.5 M | - | 1.37 % | $ 20.5 M | USA |
 |
Aethlon Medical
AEMD
|
-9.34 M | $ 2.59 | 1.17 % | $ 4.04 M | USA |